Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. (2017)

First Author: Batson J

Attributed to: Regulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.6b01048

PubMed Identifier: 28135068

Publication URI: http://europepmc.org/abstract/MED/28135068

Type: Journal Article/Review

Volume: 12

Parent Publication: ACS chemical biology

Issue: 3

ISSN: 1554-8929